AlphaFold has achieved groundbreaking advancements in protein structure prediction, exerting profound influence across biology, medicine, and drug discovery. However, its reliance on multiple sequence alignment (MSA) is inherently time-consuming due to the NP-hard nature of constructing MSAs. Quantum computing emerges as a promising alternative, compared to classical computers, offering the potentials for exponential speedup and improved accuracy on such complex optimization challenges. This work bridges the gap between quantum computing and MSA task efficiently and successfully, where we compared classical and quantum computational scaling as the number of qubits increases, and assessed the role of quantum entanglement in model performance. Furthermore, we proposed an innovative hybrid query encoding approach hyQUBO to avoid redundancy, and thereby the quantum resources significantly reduced to a scaling of $\mathcal{O}(NL)$. Additionally, coupling of VQE and the quenched CVaR scheme was utilized to enhance the robustness and convergence. The integration of multiple strategies facilitates the robust deployment of the quantum algorithm from idealized simulators (on CPU and GPU) to real-world, noisy quantum devices (HYQ-A37). To the best of our knowledge, our work represented the largest-scale implementation of digital simulation using up to 16 qubits on a trapped-ion quantum computer for life science problem, which achieved state of the art performance in both simulation and experimental results. Our work paves the way towards large-scale simulations of life science tasks on real quantum processors.
AlphaFold has achieved groundbreaking advancements in protein structure prediction, exerting profound influence across biology, medicine, and drug discovery. However, its reliance on multiple sequence alignment (MSA) is inherently time-consuming due to the NP-hard nature of constructing MSAs. Quantum computing emerges as a promising alternative, compared to classical computers, offering the potentials for exponential speedup and improved accuracy on such complex optimization challenges. This work bridges the gap between quantum computing and MSA task efficiently and successfully, where we compared classical and quantum computational scaling as the number of qubits increases, and assessed the role of quantum entanglement in model performance. Furthermore, we proposed an innovative hybrid query encoding approach hyQUBO to avoid redundancy, and thereby the quantum resources significantly reduced to a scaling of O(NL). Additionally, coupling of VQE and the quenched CVaR scheme was utilized to enhance the robustness and convergence. The integration of multiple strategies facilitates the robust deployment of the quantum algorithm from idealized simulators (on CPU and GPU) to real-world, noisy quantum devices (HYQ-A37). To the best of our knowledge, our work represented the largest-scale implementation of digital simulation using up to 16 qubits on a trapped-ion quantum computer for life science problem, which achieved state of the art performance in both simulation and experimental results. Our work paves the way towards large-scale simulations of life science tasks on real quantum processors.
Bioinformatics workloads -- including protein structure prediction, molecular dynamics simulation, genomic sequencealignment, and phylogenetic tree reconstruction -- are among the most computationally intensive problems in science,with many exhibiting exponential or combinatorial scaling that overwhelms classical high-performance computing.Quantum computing, leveraging superposition and entanglement to explore exponentially large solution spaces,promises polynomial or exponential speedups for specific bioinformatics tasks. However, current noisyintermediate-scale quantum (NISQ) devices (50-1,000+ qubits, high error rates) are far from fault-tolerant quantumcomputers, and the practical quantum advantage for bioinformatics remains undemonstrated. This study systematicallybenchmarked five computational approaches -- classical exact algorithms, classical heuristics (genetic algorithm,simulated annealing), GPU-accelerated methods, variational quantum algorithms (VQE, QAOA) on NISQ hardware, anda proposed hybrid quantum-classical bioinformatics pipeline (HQC-Bio) combining quantum subroutines for combinatorialsubproblems with classical pre/post-processing -- across four bioinformatics tasks: multiple sequence alignment (MSA, n= 500 protein families), protein folding on lattice models (HP model, chains 20-60 residues), molecular docking scoring(1,000 ligand-receptor pairs), and phylogenetic tree search (taxa sets 10-50). HQC-Bio achieved the highest solutionquality for protein folding (optimal energy found in 84.6% of 40-residue instances vs 62.4% for simulated annealing; p <0.001) and phylogenetic search (log-likelihood within 0.2% of exact ML for 30-taxa trees vs 1.8% for RAxML heuristic).However, quantum wall-clock time exceeded classical GPU by 12-340x due to NISQ hardware overhead (circuitcompilation, shot noise, error mitigation), establishing that current quantum advantage is in solution quality rather thanspeed. Resource estimation projects that fault-tolerant quantum computers with 10,000-100,000 logical qubits couldachieve genuine speedups of 10-1,000x for these tasks within 10-15 years.
A study published on the preprint repository arXiv comprehensively outlines empirical applications of quantum algorithms (such as VQE, QAOA) that can be executed on near-term noisy intermediate-scale quantum (NISQ) hardware to solve key challenges in molecular biology and drug discovery, such as protein folding and molecular docking. Through quantum simulations that overcome the limits of classical computing, it was demonstrated that by directly simulating the Hamiltonian of a chemical system, the 3D energy-minimized state of peptides or small molecule compounds can be accurately predicted with significantly fewer computing resources than before. It provides a practical roadmap for combining quantum machine learning (QML) and molecular biology to dramatically reduce massive computational costs and achieve overwhelming efficiency in the next-generation in silico drug discovery process. [Quantum Biology Society] Problems such as protein folding and molecular docking, which cause the biggest bottlenecks in the drug discovery process, become exponentially more complex as the amino acid sequence gets longer. The number of cases to explore explodes, making it difficult for classical computers to handle their NP-hard complexity. Recently, a groundbreaking demonstration framework aiming to introduce the latest quantum computing algorithms into the pharmaceutical and biotechnology fields to overcome these limitations has been presented, drawing attention from the related industry. The paper titled "Quantum computing for molecular biology," published on the preprint repository arXiv, comprehensively covers the application of practical quantum algorithms (e.g., VQE, QAOA) capable of solving drug discovery challenges that have hit the limits of classical computing, using noisy intermediate-scale quantum (NISQ) hardware. A research team including Alberto Baiardi and Markus Reiher from ETH Zurich in Switzerland, along with Matthias Christandl from the University of Copenhagen in Denmark, led this innovative convergent research. ■ Quantum Simulation: Overcoming the Limits of Classical Computing The research team demonstrated that by utilizing the characteristic of quantum computers to efficiently map and directly simulate the Hamiltonian of chemical systems, the complex 3D energy-minimized states of peptides or small molecule compounds can be accurately found with significantly fewer computing resources than before. This is because quantum computers can fundamentally bypass the "curse of dimensionality," where the computational amount expands exponentially, by naturally simulating the quantum mechanical properties of molecules. ■ A Roadmap for Next-Generation Drug Discovery This research goes beyond simply presenting algorithms; it provides a specific roadmap for next-generation in silico drug discovery processes by combining quantum machine learning (QML) and molecular biology. Through this, it has opened a path to achieve overwhelming efficiency by drastically reducing the massive computational costs and time required to screen drug candidates and optimize their most stable binding structures. This practical guide strongly suggests that quantum computing will become a core foundational technology bringing substantial innovation to the life sciences and pharmaceutical industries in the future. https://arxiv.org/abs/2212.12220
Abstract Predicting the three-dimensional structure of a protein from its primary sequence of amino acids is known as the protein folding problem. Due to the central role of proteins’ structures in chemistry, biology and medicine applications, this subject has been intensively studied for over half a century. Although classical algorithms provide practical solutions for the sampling of the conformation space of small proteins, they cannot tackle the intrinsic NP-hard complexity of the problem, even when reduced to the simplest Hydrophobic-Polar model. On the other hand, while fault-tolerant quantum computers are beyond reach for state-of-the-art quantum technologies, there is evidence that quantum algorithms can be successfully used in noisy state-of-the-art quantum computers to accelerate energy optimization in frustrated systems. In this work, we present a model Hamiltonian with O(N4) O ( N 4 ) scaling and a corresponding quantum variational algorithm for the folding of a polymer chain with N monomers on a lattice. The model reflects many physico-chemical properties of the protein, reducing the gap between coarse-grained representations and mere lattice models. In addition, we use a robust and versatile optimization scheme, bringing together variational quantum algorithms specifically adapted to classical cost functions and evolutionary strategies to simulate the folding of the 10 amino acid Angiotensin on 22 qubits. The same method is also successfully applied to the study of the folding of a 7 amino acid neuropeptide using 9 qubits on an IBM 20-qubit quantum computer. Bringing together recent advances in building gate-based quantum computers with noise-tolerant hybrid quantum-classical algorithms, this work paves the way towards accessible and relevant scientific experiments on real quantum processors.
Protein folding is a computationally intensive problem in bioinformatics that involves predicting the three-dimensional structure of a protein from its amino acid sequence. Classical approaches face challenges due to the exponential complexity of the search space. In this paper, we propose Q-ProteinFold, a quantum-classical hybrid system that leverages the Variational Quantum Eigensolver (VQE) for protein folding approximation. The system encodes protein sequences into parameterized quantum circuits using Qiskit and explores multiple conformations through quantum superposition and entanglement. A classical optimizer iteratively minimizes the energy function to identify stable protein structures. The implementation is developed using Python, Streamlit, and Qiskit Aer simulator. Experimental results demonstrate energy convergence, probabilistic state distribution, and effective fold prediction. This work highlights the potential of quantum computing in solving complex biological optimization problems.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI's predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning’s role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug-receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual's genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions. This paper provides a comprehensive analysis of the potential, challenges, and future directions of quantum-AI synergy in transforming modern healthcare.
Quantum computing is emerging as a transformative approach in bioinformatics and quantum chemistry, addressing fundamental computational limitations of classical methods in molecular science. Many biological and chemical systems are inherently governed by quantum mechanics, making accurate simulation with classical algorithms computationally expensive or infeasible. This review examines how quantum computing, particularly in the Noisy Intermediate-Scale Quantum (NISQ) era, is advancing molecular modeling, reaction dynamics, and bioinformatics applications. Key quantum algorithms, including the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE), demonstrate increasing capability in approximating molecular energies and simulating quantum systems. In parallel, applications in bioinformatics—such as protein folding, genomic search, and combinatorial optimization—highlight the potential of quantum computing to address complex biological problems. Quantum machine learning further extends these capabilities by integrating quantum algorithms with data-driven modeling. However, current progress is constrained by NISQ-era limitations, including noise, limited qubit counts, and scalability challenges. These constraints highlight the need for hybrid quantum–classical approaches and improved error mitigation strategies. Overall, quantum computing represents a complementary computational paradigm that can enhance classical methods in bioinformatics and chemistry. Continued advances in quantum algorithms, hardware, and hybrid modeling frameworks are expected to expand its role in molecular science and computational biology.